EarningsQ2 2024 Earnings Report

Nektar Therapeutics (ITH0) Q2 2024 Earnings Report

1 Followers

DE:ITH0 Q2 2024 EPS Results

Actual EPS-€3.33

Consensus EPS-€2.46

Beat/MissMissed by -€0.87

One Year Ago EPS-€3.60

Actual Revenue€20.86M

Expected Revenue€16.17M

Beat/MissBeat by +€4.69M

YoY Revenue Growth+14.59%

QuarterQ2 2024

Date08/08/2024

TimeAfter Close

Conference CallThursday, August 8, 2024

DE:ITH0 Upcoming Earnings

Nektar Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

DE:ITH0 Q2 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-1.86 / -	-1.661	―
Aug 13, 2026	2026 (Q2)	-1.75 / -1.09	-2.62	58.31% (+1.53)
May 07, 2026	2026 (Q1)	-1.41 / -1.62	-3.197	49.44% (+1.58)
Mar 12, 2026	2025 (Q4)	-2.20 / -1.58	0.4	-495.56% (-1.98)
Nov 06, 2025	2025 (Q3)	-2.38 / -1.66	-2.398	30.74% (+0.74)
Aug 07, 2025	2025 (Q2)	-2.69 / -2.62	-3.331	21.33% (+0.71)
May 08, 2025	2025 (Q1)	-2.28 / -3.20	-2.531	-26.32% (-0.67)
Mar 12, 2025	2024 (Q4)	-1.81 / 0.40	-2.931	113.64% (+3.33)
Nov 07, 2024	2024 (Q3)	-2.65 / -2.40	-3.197	25.00% (+0.80)
Aug 08, 2024	2024 (Q2)	-2.46 / -3.33	-3.597	7.41% (+0.27)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed